Table: begin end state 1 25 cytoplasmic 26 44 transmembrane 45 64 non-cytoplasmic 65 83 transmembrane 84 93 cytoplasmic 94 115 transmembrane 116 120 non-cytoplasmic 121 140 transmembrane 141 159 cytoplasmic 160 182 transmembrane 183 187 non-cytoplasmic 188 207 transmembrane 208 253 cytoplasmic 254 272 transmembrane 273 292 non-cytoplasmic 293 311 transmembrane 312 322 cytoplasmic 323 341 transmembrane 342 352 non-cytoplasmic 353 373 transmembrane 374 382 cytoplasmic 383 404 transmembrane 405 415 non-cytoplasmic 416 436 transmembrane 437 447 cytoplasmic
Input: >WP_046156002.1 NCBI__GCF_000971335.1:WP_046156002.1 MISLFKPAPHLPPLPDAQQHGLYRRLRWQIFLGIFLGYAGYYLVRKNFSLAMPYLVEQGF SRGDLGFAMSGVAIAYGLSKFLMGAVSDRSNPRVFLSAGLVLSAAVFLLMGFAPWATSSV GVMFVLLFLNGWFQGMGWPACGRTMVHWWSQKERGGVVSIWNCAHNVGGGLIGPLFILGM GWFNDWRAAFYVPAAAAIGVAVFAWLTMRDTPQSCGLPPVEAYRNDYPEDYSDTHEQELT AREIFRKYILPNKLLWYIALANVFIYLLRYGVLDWAPTYLKEVKHFSVDKSSWAYFLYEW AGIPGTLLCGWMSDKLFRGNRGATGVFFMALVTLATVVYWLNPAGNPTVDMLALIAIGFL IYGPVMLVGLHALELAPKKAAGTAAGFTGLFGYLGGSVAANAAVGYTVDHFGWDGGFALL IGSCVAAIVLLALTTWHGHQQGKLASA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server